PANOROMA study: nonperfusion, leakage areas on DMO, complications in NPDR

Video

Dr W. Lloyd Clark discusses his presentation at ASRS 2021, "Impact of nonperfusion and leakage areas on diabetic macular oedema/vision-threatening complications in nonproliferative diabetic retinopathy (NPDR)."

In his presentation at ASRS, Dr W. Lloyd Clark of the Palmetto Retina Centre in West Columbia, South Carolina, discussed the PANORAMA study’s findings on the effects of nonperfusion and leakage areas on diabetic macular oedema (DMO) and complications in nonproliferative diabetic retinopathy.

The PANORAMA study evaluated different dosing arms of intravitreal aflibercept versus sham treatment for severe nonproliferative diabetic retinopathy. Investigators found increases in leakage areas and retinal nonperfusion are associated with increased rates of centre-involved DMO and vision-threatening complications when compared to the sham-treated group.

Clark presented his talk, "Impact of nonperfusion and leakage areas on diabetic macular oedema/vision-threatening complications in nonproliferative diabetic retinopathy (NPDR)" on Saturday, the 9th of October, 2021 at the ASRS 39th Annual Scientific Meeting in San Antonio, Texas.

Read more about the PANORAMA study

The American Society of Retina Specialists (ASRS) hosted its 39th Annual Scientific Meeting from the 8th to the 12th of October, 2021, at the JW Marriott San Antonio Hill Country Resort and Spa in San Antonio, Texas.

According to ASRS, its 2021 scientific programme offered attendees innovations in retina science, clinical practice and surgery with 148 papers, 165 posters, 46 papers on demand, and 69 films, as well as a wide range of networking opportunities and the chance to exchange ideas and perspectives with peers.

Related Content: Conference Coverage | Retina | Inflammation & Infection

Recent Videos
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
At EURETINA 2024, Martin S. Zinkernagel, MD, PhD, on the future of real-world AI use
© 2024 MJH Life Sciences

All rights reserved.